Marlous L Grijsen

Summary

Affiliation: Academic Medical Center
Country: The Netherlands

Publications

  1. doi Low bone mineral density, regardless of HIV status, in men who have sex with men
    Marlous L Grijsen
    Department of Internal Medicine, Division of Infectious Diseases, Center for Infection and Immunity Amsterdam, Amsterdam, The Netherlands
    J Infect Dis 207:386-91. 2013
  2. doi No advantage of quadruple- or triple-class antiretroviral therapy as initial treatment in patients with very high viraemia
    Marlous L Grijsen
    Department of Internal Medicine, Division of Infectious Diseases, Academic Medical Center, University of Amsterdam, Center for Infection and Immunity Amsterdam, The Netherlands
    Antivir Ther 17:1609-13. 2012
  3. pmc No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial
    Marlous L Grijsen
    Department of Internal Medicine, Division of Infectious Diseases, Center for Infection and Immunity, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    PLoS Med 9:e1001196. 2012
  4. doi High prevalence of reduced bone mineral density in primary HIV-1-infected men
    Marlous L Grijsen
    Academic Medical Center, University of Amsterdam, Department of Internal Medicine, The Netherlands
    AIDS 24:2233-8. 2010
  5. ncbi HIV-1 dual infection is associated with faster CD4+ T-cell decline in a cohort of men with primary HIV infection
    Marion Cornelissen
    Laboratory of Experimental Virology, Academic Medical Center, University of Amsterdam, Netherlands
    Clin Infect Dis 54:539-47. 2012
  6. pmc Activity of broadly neutralizing antibodies, including PG9, PG16, and VRC01, against recently transmitted subtype B HIV-1 variants from early and late in the epidemic
    Zelda Euler
    Department of Experimental Immunology, Sanquin Research, Landsteiner Laboratory, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    J Virol 85:7236-45. 2011
  7. pmc Temporary Treatment during Primary HIV Infection Does Not Affect Virologic Response to Subsequent Long-Term Treatment
    Marlous L Grijsen
    Academic Medical Center, University of Amsterdam, Department of Internal Medicine, Division of Infectious Diseases, Center for Infection and Immunity Amsterdam, Amsterdam, The Netherlands
    PLoS ONE 9:e89639. 2014
  8. doi Altered dynamics and differential infection profiles of lymphoid and myeloid cell subsets during acute and chronic HIV-1 infection
    Mireille Centlivre
    Laboratories of Experimental Virology, Department of Medical Microbiology, Center for Infection andImmunity Amsterdam, Tropical Medicine and AIDS, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands
    J Leukoc Biol 89:785-95. 2011
  9. doi A Case of Kaposi's Sarcoma during Primary HIV-1 Infection
    Marlous L Grijsen
    1Department of Internal Medicine, Division of Infectious Diseases, Center for Infection and Immunity Amsterdam CINIMA, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
    J Int Assoc Physicians AIDS Care (Chic) 10:349-50. 2011
  10. ncbi Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level
    Evelien M Bunnik
    Department of Experimental Immunology, Sanquin Research, Landsteiner Laboratory, Center for Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Nat Med 16:995-7. 2010

Collaborators

Detail Information

Publications10

  1. doi Low bone mineral density, regardless of HIV status, in men who have sex with men
    Marlous L Grijsen
    Department of Internal Medicine, Division of Infectious Diseases, Center for Infection and Immunity Amsterdam, Amsterdam, The Netherlands
    J Infect Dis 207:386-91. 2013
    ..In the multivariate analyses, HIV infection was not associated with BMD, suggesting that low BMD previously reported in HIV-infected MSM may predate HIV acquisition...
  2. doi No advantage of quadruple- or triple-class antiretroviral therapy as initial treatment in patients with very high viraemia
    Marlous L Grijsen
    Department of Internal Medicine, Division of Infectious Diseases, Academic Medical Center, University of Amsterdam, Center for Infection and Immunity Amsterdam, The Netherlands
    Antivir Ther 17:1609-13. 2012
    ..The assessment was made based on a national observational HIV cohort in the Netherlands...
  3. pmc No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial
    Marlous L Grijsen
    Department of Internal Medicine, Division of Infectious Diseases, Center for Infection and Immunity, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    PLoS Med 9:e1001196. 2012
    ..The objective of this study was to assess the benefit of temporary combination antiretroviral therapy (cART) during primary HIV infection (PHI)...
  4. doi High prevalence of reduced bone mineral density in primary HIV-1-infected men
    Marlous L Grijsen
    Academic Medical Center, University of Amsterdam, Department of Internal Medicine, The Netherlands
    AIDS 24:2233-8. 2010
    ..To assess the bone mineral density (BMD) in a cohort of men with primary HIV-1 infection (PHI)...
  5. ncbi HIV-1 dual infection is associated with faster CD4+ T-cell decline in a cohort of men with primary HIV infection
    Marion Cornelissen
    Laboratory of Experimental Virology, Academic Medical Center, University of Amsterdam, Netherlands
    Clin Infect Dis 54:539-47. 2012
    ..The objective of the present study is to analyze the effect of dual HIV-1 infections on disease progression in a well-defined cohort of men who have sex with men...
  6. pmc Activity of broadly neutralizing antibodies, including PG9, PG16, and VRC01, against recently transmitted subtype B HIV-1 variants from early and late in the epidemic
    Zelda Euler
    Department of Experimental Immunology, Sanquin Research, Landsteiner Laboratory, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    J Virol 85:7236-45. 2011
    ..These results suggest that a vaccine capable of eliciting multiple BrNAb specificities will be necessary for protection of the population against HIV-1 infection...
  7. pmc Temporary Treatment during Primary HIV Infection Does Not Affect Virologic Response to Subsequent Long-Term Treatment
    Marlous L Grijsen
    Academic Medical Center, University of Amsterdam, Department of Internal Medicine, Division of Infectious Diseases, Center for Infection and Immunity Amsterdam, Amsterdam, The Netherlands
    PLoS ONE 9:e89639. 2014
    ..Our data demonstrate that fear of drug resistance development is not a valid argument to refrain from temporary early treatment during PHI. ..
  8. doi Altered dynamics and differential infection profiles of lymphoid and myeloid cell subsets during acute and chronic HIV-1 infection
    Mireille Centlivre
    Laboratories of Experimental Virology, Department of Medical Microbiology, Center for Infection andImmunity Amsterdam, Tropical Medicine and AIDS, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands
    J Leukoc Biol 89:785-95. 2011
    ..Overall, our results demonstrate that non-T cell compartments are a major HIV-1 DNA reservoir, and CD16(+) monocytes and CD16(+) cDCs potentially play an important role in HIV-1 dissemination...
  9. doi A Case of Kaposi's Sarcoma during Primary HIV-1 Infection
    Marlous L Grijsen
    1Department of Internal Medicine, Division of Infectious Diseases, Center for Infection and Immunity Amsterdam CINIMA, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
    J Int Assoc Physicians AIDS Care (Chic) 10:349-50. 2011
    ..We present a case of KS which was diagnosed during primary HIV-1 infection. This report aims to draw attention that KS may occur early in the course of HIV-1 infection and that primary HIV-1 infection may rapidly progress to AIDS...
  10. ncbi Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level
    Evelien M Bunnik
    Department of Experimental Immunology, Sanquin Research, Landsteiner Laboratory, Center for Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Nat Med 16:995-7. 2010
    ..The enhanced neutralization resistance of HIV-1 in contemporary seroconverters coincided with the poorer elicitation of neutralizing antibody responses, which may have implications for vaccine design...